山東威高(01066)回购6万股股份，总额约31.42万港元

公告速递02-23

山東威高集團醫用高分子製品股份有限公司(01066)于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。

公司购回授权于2025年5月27日获股东大会通过，可回购股份上限为451,560,392股，截至公告日合计已回购34,933,600股，占授权总数的约7.7362%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。本次公告由公司秘书黄妙玲签署。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1144964806?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-23 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144964806","market":"hk","top_or_hot":-1,"title":"山東威高(01066)回购6万股股份，总额约31.42万港元","media":"公告速递","content":"<p>山東威高集團醫用高分子製品股份有限公司(01066)于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。</p>\n<p>公司购回授权于2025年5月27日获股东大会通过，可回购股份上限为451,560,392股，截至公告日合计已回购34,933,600股，占授权总数的约7.7362%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。本次公告由公司秘书黄妙玲签署。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>山東威高(01066)回购6万股股份，总额约31.42万港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n山東威高(01066)回购6万股股份，总额约31.42万港元\n</h2>\n\n<h4 class=\"meta\">\n\n2026-02-23 17:02 北京时间&nbsp;&nbsp;&nbsp;<strong>公告速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>山東威高集團醫用高分子製品股份有限公司(01066)于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。\n公司...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1144964806","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144964806","pubTimestamp":1771837329,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"山東威高集團醫用高分子製品股份有限公司于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。公司购回授权于2025年5月27日获股东大会通过，可回购股份上限为451,560,392股，截至公告日合计已回购34,933,600股，占授权总数的约7.7362%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01066":"威高股份"},"translate_title":"Shandong Weigao (01066) repurchased 60,000 shares, totaling approximately HK $314,200","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"山東威高集團醫用高分子製品股份有限公司(01066)于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。\n公司购回授权于2025年5月27日获股东大会通过，可回购股份上限为451,560,392股，截至公告日合计已回购34,933,600股，占授权总数的约7.7362%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。本次公告由公司秘书黄妙玲签署。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144964806","isCrawlerRequest":true}